Selodenoson

Selodenoson is under investigation in clinical trial NCT00040001 (Safety and Efficacy Study of an A1-adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation). The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Selodenosonum. Its PubChem CID is 3082555.

CAS No 110299-05-3
Molecular Formula C17H24N6O4
Molecular Weight 376.4 g/mol
Synonyms (2S,3S,4R,5R)-5-[6-(cyclopentylamino)purin-9-yl]-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide

Frequently Asked Questions